G28UCM

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameG28UCM
Drug Alias NameFatty acid synthase inhibitor (Pfizer)G28UCM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty acid synthase inhibitors
TargetsFatty acid synthase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A